Quarry LP Sells 2,246 Shares of Masimo Co. (NASDAQ:MASI)

Quarry LP trimmed its holdings in shares of Masimo Co. (NASDAQ:MASI) by 63.7% in the second quarter, according to its most recent filing with the SEC. The firm owned 1,279 shares of the medical equipment provider’s stock after selling 2,246 shares during the period. Quarry LP’s holdings in Masimo were worth $161,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in MASI. Riverview Trust Co bought a new position in shares of Masimo during the 1st quarter worth about $25,000. GAMMA Investing LLC lifted its holdings in shares of Masimo by 75.0% during the 2nd quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 111 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in shares of Masimo by 133.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 200 shares in the last quarter. Parallel Advisors LLC increased its position in shares of Masimo by 48.3% during the 4th quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider’s stock worth $52,000 after purchasing an additional 145 shares in the last quarter. Finally, HHM Wealth Advisors LLC increased its position in shares of Masimo by 25.0% during the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock worth $79,000 after purchasing an additional 125 shares in the last quarter. 85.96% of the stock is owned by institutional investors.

Masimo Trading Up 0.1 %

MASI opened at $133.33 on Tuesday. The company has a current ratio of 2.09, a quick ratio of 1.15 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $7.09 billion, a PE ratio of 90.70 and a beta of 0.98. Masimo Co. has a 1-year low of $75.22 and a 1-year high of $153.93. The firm has a 50-day moving average price of $117.20 and a two-hundred day moving average price of $124.91.

Masimo (NASDAQ:MASI) last posted its quarterly earnings data on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.09. The firm had revenue of $496.30 million during the quarter, compared to analysts’ expectations of $493.92 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.62 EPS. As a group, equities analysts anticipate that Masimo Co. will post 3.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Friday, September 20th. Piper Sandler increased their target price on shares of Masimo from $160.00 to $165.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, Masimo has a consensus rating of “Moderate Buy” and an average price target of $144.67.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.